| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Feb 25 | ALLO Allogene Therapeutics | Common Stock | Sell | Dispose S | No | No | 1.7 | 18,832 | 32.01 k | 643,135 |
| 24 Jan 25 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 173,913 | 0.00 | 661,967 |
| 24 Jan 25 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.94 | 614,844 | 1.19 mm | 614,844 |
| 21 Jan 25 | ALLO Allogene Therapeutics | Common Stock | Sell | Dispose S | No | No | 1.78 | 27,199 | 48.41 k | 488,054 |
| 25 Jan 24 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 140,000 | 0.00 | 515,253 |
| 25 Jan 24 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.2 | 494,949 | 1.58 mm | 494,949 |
| 22 Jan 24 | ALLO Allogene Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 3.1744 | 24,690 | 78.38 k | 375,253 |
